Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Pathology: Prognostic and Diagnostic Genomic Markers for Myeloid Neoplasms.

Surgical pathology clinics - 1 Sept 2016

Kuo Frank C

Abstract excerpt

Application of next-generation sequencing (NGS) on myeloid neoplasms has expanded our knowledge of genomic alterations in this group of diseases. Genomic alterations in myeloid neoplasms are complex, heterogeneous, and not specific to a disease entity. NGS-based panel testing of myeloid neoplasms can complement existing diagnostic modalities and is gaining acceptance in the clinics and diagnostic laboratories....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to DNA Mutational Analysis
Share to Genomics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hematologic Neoplasms

Share to High-Throughput Nucleotide Sequencing

Share to Leukemia, Myeloid, Acute

Share to Pathology, Molecular

Share to Prognosis

Source

Identifiers

PMID: 27523973
DOI: 10.1016/j.path.2016.04.010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Pathology: Prognostic and Diagnostic Genomic Markers for Myeloid Neoplasms.PMID 27523973Read ↗

Molecular findings in myeloid neoplasms.Semantic proximity Read ↗

Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.Semantic proximity Read ↗

Advances in Diagnosis and Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes.Semantic proximity Read ↗

Guide to the Diagnosis of Myeloid Neoplasms: A Bone Marrow Pathology Group Approach.Semantic proximity Read ↗

Targeted next-generation sequencing using a multigene panel in myeloid neoplasms: Implementation in clinical diagnostics.Semantic proximity Read ↗

Next-Generation Sequencing Improves Diagnosis, Prognosis and Clinical Management of Myeloid NeoplasmsSemantic proximity Read ↗

The biology and clinical impact of genetic lesions in myeloid malignancies.Semantic proximity Read ↗

Acute Myeloid Leukemia Genetics: Risk Stratification and Implications for Therapy.Semantic proximity Read ↗

Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcomaSemantic proximity Read ↗

Molecular Diagnostic Testing for Hematopoietic Neoplasms: Linking Pathogenic Drivers to Personalized Diagnosis.Semantic proximity Read ↗

Myeloid somatic mutation panel testing in myeloproliferative neoplasms.Semantic proximity Read ↗

Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine useSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.